Thanks TJ. Was happy to grab 19’s yesterday. Charts are amazing. They track out exactly what’s happening to this stock. I’m sad to say there is dilution going on. I’d say about 200k shares a day and those shares are being used to undercut the ask. Anytime you see a MM come in with a 5 figure Ask and you try to slap it but it doesn’t move? He’s just unloading shares. I buy the majority of my shares now by dilution. If the MM is asking 35k (yesterday’s amount) I doubled it to 70k and when it fills and the ask stays right at 35k you know it’s manipulation. When slapping the ask does not work to move the share price to a higher MM’s ask that’s just blatant dilution IMO.
I’m a straight shooter and I see the negatives in this stock, acknowledging the poor decision to buy this shell without carefully checking it out. That sucked, but I could have made the same mistake. It happens. I’m the kinda guy that, if I make a mistake I try to find the silver lining, make lemonade out of lemons etc. most of the time it ends up working out just fine, but the lesson was costly. I’m sure BB can relate. I see our boy as a man just like us, human and learning as he goes. That’s called life!
It’s all being fixed as we speak. We are just waiting on the formalities. Meanwhile on the other side, Jason’s little company has grown by leaps and bounds and in a matter of months thanks to the hard work of Jason, Rob Mercer, Jason Coyne and Jay O’Donnell. Those latter two guys like what Jason brings to the table for THEIR products. It’s like adding turbo boost to a slow car. They were very happy to join forces as soon as they could. Add ArcMail which really looks like a great fit for our suite of products...They’ve got customers and a nice platform now AND Jason’s still not finished.
We are providing HIPAA compliance software for Hemp industry as well. Blockchain, AI. Many irons in the fire.
We currently have a A/S of 8.8b with about a 6.8b estimated float IMO. Assuming max dilution happens (i like conservative numbers) and we max out the O/S. Let’s round off to 9 mil for the sake of argument. Assuming we have a revenue run rate of 10 million for this year, just on our accretive acquisitions alone this stock is worth .011 cents. At 25 times earnings we have .025. These are conservative estimates based only on accretive revenues from Modevity and N8 customers. What about the TONS of partners? 0 sales in 2018!? LMAO!!!
That’s just the acquisitions alone. Any ClassiDocs revenues added to the mix this year is gravy. I’m throwing out extremely conservative numbers but expecting much better than that. I don’t see this getting above 8 billion O/S thanks to the Chinese shares funding ours next acquisition. This could work out much much better than we think. Short term, 10x profits from these levels IMO. Long term however; the sky is the limit.
Enjoy the cheapies while they last. Tomorrow we will have another piece of the puzzle completed with the SEC.
Stay Classi Longs!
GLTA- WIC
News 
Market Data 
Discover 
